Mutation-guided therapeutics.
Where this comes from
- Record sourced from PubMed, PMID 35389812.
- Also identified by DOI 10.1126/science.abo4237.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Development of bispecific antibodies to target mutant peptides in cancer.
Medical subject headings
- Antibodies, Bispecific
- Neoplasms